Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 4
2014 4
2015 16
2016 7
2017 5
2018 8
2019 8
2020 7
2021 9
2022 9
2023 5
2024 14
2025 14
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Markers and Targets in Melanoma.
Teixido C, Castillo P, Martinez-Vila C, Arance A, Alos L. Teixido C, et al. Cells. 2021 Sep 5;10(9):2320. doi: 10.3390/cells10092320. Cells. 2021. PMID: 34571969 Free PMC article. Review.
Melanoma on congenital melanocytic nevi.
Alos L, Carrasco A, Teixidó C, Szumera-Ciećkiewicz A, Vicente A, Massi D, Carrera C. Alos L, et al. Among authors: teixido c. Pathol Res Pract. 2024 Apr;256:155262. doi: 10.1016/j.prp.2024.155262. Epub 2024 Mar 11. Pathol Res Pract. 2024. PMID: 38518732 Review.
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC.
Ortiz-Cuaran S, Dupriez L, Nicq C, Lindsay CR, Mazieres J, Santamaría D, Ambrogio C, Calvayrac O, Teixido C, Friboulet L, Novello S, Tabbò F, Swalduz A, Nadal E, Planchard D, Mezquita L, Nokin MJ; BOLERO Consortium. Ortiz-Cuaran S, et al. Among authors: teixido c. J Thorac Oncol. 2026 Apr;21(4):103531. doi: 10.1016/j.jtho.2025.12.001. Epub 2026 Jan 19. J Thorac Oncol. 2026. PMID: 41553307 Free article. Review.
Vaccine Therapy in Non-Small Cell Lung Cancer.
García-Pardo M, Gorria T, Malenica I, Corgnac S, Teixidó C, Mezquita L. García-Pardo M, et al. Among authors: teixido c. Vaccines (Basel). 2022 May 9;10(5):740. doi: 10.3390/vaccines10050740. Vaccines (Basel). 2022. PMID: 35632496 Free PMC article. Review.
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study.
Varela M, Teixidó C, Álvarez-Fernández C, Arasanz H, Peralta S, Lázaro M, Calvo V, Álvarez R, Baena J, Valdivia J, Arriola E, Bernabé R, Isla D, Camacho C, Massutí B, Blasco A, García T, Cobo M, Campayo M, Hijazo-Pechero S, Callejo Á, Domínguez M, Nadal E. Varela M, et al. Among authors: teixido c. Transl Lung Cancer Res. 2025 Apr 30;14(4):1254-1265. doi: 10.21037/tlcr-2024-1146. Epub 2025 Apr 21. Transl Lung Cancer Res. 2025. PMID: 40386732 Free PMC article.
Prevalence and characteristics of lung cancer in families harboring Pathogenic Germline Variants in cancer predisposing genes: A 20-year retrospective analysis.
Laguna JC, Moreno L, Potrony M, Grau E, Pastor B, Mena-Guerrero J, Jiménez M, Gorria T, Puig-Butillé JA, Reguart N, Cajal TRY, Teixido C, Mezquita L. Laguna JC, et al. Among authors: teixido c. Eur J Cancer. 2025 Jul 25;225:115571. doi: 10.1016/j.ejca.2025.115571. Epub 2025 Jun 6. Eur J Cancer. 2025. PMID: 40527197
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).
García-Pardo M, García de Herreros M, Auclin E, Ferriol-Galmes M, Laguna JC, Gorría T, Caravaca G, Sart J, Albarrán-Artahona V, López-Castro R, Teixidó C, Castellano G, Martínez Bedmar A, Arcocha A, Alcolea L, Jiménez M, Bernabeu M, Delgado-Cano D, Navarro A, Prat A, Reguart N, Elio J, Garrido P, Leighl NB, Besse B, Mezquita L. García-Pardo M, et al. Among authors: teixido c. Ther Adv Med Oncol. 2025 Jun 26;17:17588359251351449. doi: 10.1177/17588359251351449. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40585875 Free PMC article.
Targeting molecular alterations in non-small-cell lung cancer: what's next?
López-Castro R, García-Peña T, Mielgo-Rubio X, Riudavets M, Teixidó C, Vilariño N, Couñago F, Mezquita L. López-Castro R, et al. Among authors: teixido c. Per Med. 2022 Jul;19(4):341-359. doi: 10.2217/pme-2021-0059. Epub 2022 Jun 24. Per Med. 2022. PMID: 35748237 Review.
107 results